Literature DB >> 10644985

Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31.

K Namba1, M Abe, S Saito, M Satake, T Ohmoto, T Watanabe, Y Sato.   

Abstract

Mice lacking the AML1/PEBP2alphaB/CBFa2 gene or PEBP2beta/CBFb gene exhibit a defect in definitive hematopoiesis and die in utero because of hemorrhage in the central nervous system. Hematopoiesis in the embryo is considered to be tightly associated with vascular development. Here we examined whether PEBP2/CBF plays any role in angiogenesis besides that in definitive hematopoiesis. We found that AML1/PEBP2alphaB/CBFa2, PEBP2alphaA/CBFa1, and PEBP2beta/CBFb were expressed in a murine endothelial cell line MSS31. The expression of these molecules as well as the DNA binding activity of PEBP2/CBF were augmented by angiogenic growth factors such as bFGF and VEGF. Moreover, the expression of PEBP2 alpha/CBFa protein in endothelial cells was confirmed at the site of angiogenesis in vivo. To further clarify the role of PEBP2/CBF in angiogenesis, we established permanent transfectants of PEBP2 beta-MYH11 gene, one that interacts with the runt domain of the alpha subunit and deregulates PEBP2/CBF in a dominant interfering manner. Proliferation, migration, and tube formation of the PEBP2 beta-MYH11 transfectants were significantly reduced in comparison with those activities of the mock transfectants. These results suggest that transcription factor PEBP2/CBF plays an important role in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644985     DOI: 10.1038/sj.onc.1203257

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Identification of RUNX1 as a Mediator of Aberrant Retinal Angiogenesis.

Authors:  Jonathan D Lam; Daniel J Oh; Lindsay L Wong; Dhanesh Amarnani; Cindy Park-Windhol; Angie V Sanchez; Jonathan Cardona-Velez; Declan McGuone; Anat O Stemmer-Rachamimov; Dean Eliott; Diane R Bielenberg; Tave van Zyl; Lishuang Shen; Xiaowu Gai; Patricia A D'Amore; Leo A Kim; Joseph F Arboleda-Velasquez
Journal:  Diabetes       Date:  2017-04-11       Impact factor: 9.461

2.  Glucose-activated RUNX2 phosphorylation promotes endothelial cell proliferation and an angiogenic phenotype.

Authors:  Adam D Pierce; Ian E Anglin; Michele I Vitolo; Maria T Mochin; Karen F Underwood; Simeon E Goldblum; Sravya Kommineni; Antonino Passaniti
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

3.  CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus.

Authors:  Ling Zhao; Jennifer L Cannons; Stacie Anderson; Martha Kirby; Liping Xu; Lucio H Castilla; Pamela L Schwartzberg; Rémy Bosselut; P Paul Liu
Journal:  Blood       Date:  2006-12-21       Impact factor: 22.113

4.  Physical and functional interactions between Runx2 and HIF-1α induce vascular endothelial growth factor gene expression.

Authors:  Tae-Geon Kwon; Xiang Zhao; Qian Yang; Yan Li; Chunxi Ge; Guisheng Zhao; Renny T Franceschi
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

5.  A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.

Authors:  T Takahashi; S Yamaguchi; K Chida; M Shibuya
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

6.  Hyperglycemia regulates RUNX2 activation and cellular wound healing through the aldose reductase polyol pathway.

Authors:  David R D'Souza; Maryann M Salib; Jessica Bennett; Maria Mochin-Peters; Kaushal Asrani; Simeon E Goldblum; Keli J Renoud; Paul Shapiro; Antonino Passaniti
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

7.  Hyperglycemia and redox status regulate RUNX2 DNA-binding and an angiogenic phenotype in endothelial cells.

Authors:  Maria T Mochin; Karen F Underwood; Brandon Cooper; John C McLenithan; Adam D Pierce; Cesar Nalvarte; Jack Arbiser; Anna I Karlsson; Alexander R Moise; Jackob Moskovitz; Antonino Passaniti
Journal:  Microvasc Res       Date:  2014-10-02       Impact factor: 3.514

8.  Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1.

Authors:  Hiroki Miyashita; Tatsuaki Watanabe; Hideki Hayashi; Yasuhiro Suzuki; Takanobu Nakamura; Soichi Ito; Manabu Ono; Yasushi Hoshikawa; Yoshinori Okada; Takashi Kondo; Yasufumi Sato
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

9.  JunB is required for endothelial cell morphogenesis by regulating core-binding factor beta.

Authors:  Alexander H Licht; Oliver T Pein; Lore Florin; Bettina Hartenstein; Hendrik Reuter; Bernd Arnold; Peter Lichter; Peter Angel; Marina Schorpp-Kistner
Journal:  J Cell Biol       Date:  2006-12-11       Impact factor: 10.539

10.  Effect of thrombin peptide 508 (TP508) on bone healing during distraction osteogenesis in rabbit tibia.

Authors:  Lisa R Amir; Gang Li; Ton Schoenmaker; Vincent Everts; Antonius L J J Bronckers
Journal:  Cell Tissue Res       Date:  2007-07-17       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.